Archive for the ‘Health’ Category

800px-leve-personne_bras_telescopiqueNew U.S. Bureau of Labor Statistics (BLS) data on worker injuries shows that nursing assistants remain at high risk of workplace injuries, despite an overall decline in worker injuries across industries in 2015.  Last year, these workers had among the highest number of injuries and illnesses resulting in days away from work, alongside “heavy and tractor-trailer truck drivers” and “laborers and freight, stock, and material movers.” The BLS data is compiled from the agency’s 2015 Survey of Occupational Injuries and Illnesses, an annual survey of non-fatal work-related injuries and illnesses from selected employers.

But the story doesn’t end there.  It is important to note that nursing assistants also experienced musculoskeletal disorders (MSDs) at a rate of 171 cases per 10,000 full-time workers.  MSDs are injuries to the muscles, nerves and tendons of the limbs and lower back. Nursing assistants and other health care workers often develop MSDs from lifting and moving patients manually on a regular basis, requiring time off work to recover.

Public Citizen released a five-part series “Nursing: A Profession in Peril,” which showed how nursing employees injured while moving patients suffered lasting chronic pain, depression and reduced mobility. Many of these injuries have devastating and lifelong consequences, even causing some workers to lose their jobs when they could no longer fulfill their lifting duties.

Part four of the series documented that some health care employers have addressed this problem by implementing programs that replace manual lifting with equipment such as portable lifts and slide boards. Not only do these programs keep workers safe – they also save employers money. Studies show that employers recover expenses within approximately four years of implementation due to factors such as reduced workers’ compensation payments for manual lifting injuries.

Although 11 states have passed laws to respond to the MSD injury crisis, there is currently no federal standard requiring health care employers to protect workers by implementing safe patient handling programs in their facilities. Such a standard would be critical in preventing MSDs among nurses and other health care workers. Despite the fact that President-Elect Trump claims he will take actions to “protect American workers” within his first 100 days in office, his plan does not actually outline any details for addressing worker safety.  Furthermore, his administration has threatened a temporary moratorium on all new regulations, which will likely include halting important public health and safety rules.

While advocates await the next administration’s plan to improve occupational health and safety, one thing is certain – nursing employees deserve safe workplaces just like all other working people.

Emily Gardner is the worker health and safety advocate for Public Citizen’s Congress Watch division.

Keep up with Public Citizen’s work on these issues by following @SafeWorkers on Twitter.

By: Emily Gardner & Sammy Almashat

All children – regardless of immigration status – deserve a safe childhood free of the toxic effects of nicotine poisoning. A recent article in The Washington Post Magazine highlights the devastating conditions on tobacco farms, where employers permit young children to labor for hours on end in the sweltering heat, often providing little access to water or protective gear. As a result of handling tobacco plants, child tobacco workers may experience symptoms consistent with acute nicotine poisoning, including nausea, vomiting, headaches, and dizziness. Many of the children and their parents are undocumented, leaving them vulnerable to employer exploitation. (In recent years, Human Rights Watch has documented the dire conditions for child workers on tobacco farms.)

tobacco-837764_640Take the case of Eddie Ramirez, one of the teenagers profiled in the Post article. Eddie, age 17, has been working in the fields since he was only 12 years old, even though he initially found tobacco work unbearable. Although he tried finding other, safer jobs, only tobacco farms would allow him to work without a green card or U.S. citizenship.

Many supporters of child tobacco labor argue that children like Eddie need to do this dangerous work in order to help their families make ends meet. Unfortunately, the Post’s article offers little critique of this flawed argument. In the early days of the Industrial Revolution, child labor proponents used similar arguments to justify children toiling in perilous factory jobs for low wages, a chapter in American history being replayed on tobacco and other farms today. In addition to putting children’s health at risk, child labor perpetuates the cycle of poverty by interrupting children’s education and limiting their future prospects.

Failing to protect children from hazardous labor is unacceptable. However, current U.S. law still permits children – younger than 12 years old in some circumstances – to work on tobacco farms, exposing them to nicotine, pesticides, and other dangerous conditions that could have long-term health consequences.  In 2011, the U.S. Department of Labor (DOL) proposed a rule which would have banned child labor in tobacco and certain other hazardous work in agriculture.

Unfortunately, DOL pulled the rule in 2012 under intense pressure from agribusiness.

Recently, labor and children’s advocates have demanded that the government renew its efforts to prevent children from working in direct contact with tobacco in U.S. agriculture. Over 100 groups and nearly 50 members of Congress wrote letters calling on President Obama to ban this practice. In the final days of the Obama administration, our government should correct the grave mistake it made in 2012 and end the exploitation of child tobacco workers.

Emily Gardner is the worker health and safety advocate for Public Citizen’s Congress Watch division. Sammy Almashat is a researcher with Public Citizen’s Health Research Group.

Keep up with Public Citizen’s work on these issues by following @SafeWorkers on Twitter.

Each day this week we’ll be highlighting some of the anti-regulatory bills that Public Citizen and our allies have been pushing back against this fall.

Image courtesy of Eric Lynch/Flickr under CC BY-NC-ND 2.0 license.

Image courtesy of Eric Lynch/Flickr under CC BY-NC-ND 2.0 license.

When Congress returned from its longest summer recess in 60 years, and before they ran back to districts to campaign, conservatives in the U.S. House of Representatives were determined to assail our system of public protections. Remember that arcade game staple, whack-a-mole, where players try to hammer down the target as others pop up, more and more quickly?  Essentially playing whack-a-mole in the four weeks of September, Public Citizen and our partners in the Coalition for Sensible Safeguards defended against multiple pieces of legislation aimed at limiting the power of the government to protect the public.

Conservatives attempted to pass four misleading and damaging anti-regulatory bills and were successful in pushing through three of them – the fourth was shelved until Congress’ post-election return.

  • Stop Settlement Slush Funds Act (H.R. 5063) – passed on Sept. 7, 2016
  • Regulatory Integrity Act (H.R. 5226) – passed on Sept. 14, 2016
  • REVIEW Act (H.R. 3438) – passed on Sept. 21, 2016
  • Midnight Rules Relief Act (H.R. 5982) – shelved for the lame duck on Sept. 26, 2016

Regulations protect and safeguard our lives in everything from the food we eat to the water we drink and from the air we breathe to the products we use. These government standards ensure that we can go about our daily lives without much fear of dying at work, eating poisonous food or having our cars go up in flames. The process for producing these vital standards is already glacially slow and exceedingly cumbersome, and if signed into law, these damaging bills would exacerbate the problems in the rulemaking system.

The slow process of our current rulemaking system already has a negative impact on communities of color and low income communities, who it has been shown face the biggest health, safety and economic threats and inequities in public protections.  Further delays to public safeguards would do nothing but increase this disproportionate impact, heightening the injustices and inequities in our society.

These bills that conservatives rushed through would prolong and further delay lifesaving rules from reaching full enforcement and having maximum impact. They aren’t about protecting the public good; they’re about helping industry line their own pockets at the expense of the American people. The bills were cleverly designed to use back door approaches to gut key safeguards. And, since the bill titles were designed to be bland and meaningless, here they are re-named to call them out for what they really are.

Just some of the over 700,000 signature delivered to Mylan

Just some of the over 700,000 signature delivered to Mylan, Photo Credit: Ed Grystar W. PA. Coalition for Single Payer Healthcare

By Sean Grant

Protesters on Tuesday delivered petitions to Mylan’s corporate headquarters just outside of Pittsburgh demanding that the company end price gouging EpiPen users, they did not expect a warm welcome. They knew beforehand that they would not be allowed to approach the building. In front of TV cameras, Mylan accepted the petitions on a wheeled cart.

But Mylan representatives who collected the petition signatures – gathered by Public Citizen, MoveOn.org Civic Action and others – offered no comment to the media, raising the question of whether the company will heed the call of the nearly 700,000 Americans who signed the petitions. The public clearly is outraged at Mylan’s raising the price of EpiPens by more than 500 percent since 2007 for no apparent reason other than greed.

Protesters were not allowed to enter Mylan's visitor entrance at their building

Protesters were not allowed to enter Mylan’s visitor entrance, Photo Credit: Ed Grystar W. PA. Coalition for Single Payer Healthcare

Before the petition delivery, Mylan twice announced new measures to appease the public, but these weak attempts at appearing contrite only further enraged people. As Public Citizen President Robert Weissman stated, “It’s not enough to offer coupons and it’s not enough to offer an overpriced generic version of its own branded product. The company must roll back its unjustified and outrageous price increases.” Read those press releases here and here.

As the petitions were rolled away on dollies to chants of “people over profit,” attention shifted to Mike Laffin, a member of Mylan’s communications team, who was sent out to deal with the reporters clamoring to ask questions. Laffin, however, could provide nothing more substantive than “Any other questions need to be directed to our communications team or customer service.” He repeated the phrase several times, perhaps most forcefully when one reporter asked if Mylan had any plans to lower the price of the EpiPen further.

Considering how ineffective the customer service department has been so far, referring reporters to it – by a live person from the communications department – doesn’t seem like the brightest PR move. But the company keeps making missteps, it seems. It is imperative Mylan finally listen and take substantive action.

View a video of the petition delivery 

 

By Anisha Sehgal

Both consumers and healthcare payers are struggling with the rising price of drugs. Unless meaningful reforms are enacted, this problem will only get larger and patients will continue to face crippling out-of-pocket costs in order to care for themselves and their loved ones. The Medicare Part B demonstration is an example of such a reform and would begin to repair the dysfunctional way that we pay for prescription drugs. Unfortunately for patients, the pharmaceutical industry has mounted considerable opposition to this reform and it is not alone. Politicians and organizations such as patients’ groups have also voiced their objection. However, the majority of these individuals and groups have received industry funding.

A recent Public Citizen report revealed that of the 147 patients’ groups who have signed letters objecting to the Medicare Part B demonstration at least 110 (75%) received funding from pharmaceutical or medical device corporations. Since patients’ groups are not required to disclose their funding sources there may be even more than the 110 groups identified by the report that received money from pharma.

The letter organized by the Community Oncology Alliance was sent to congressional leadership while the letter organized by the Partnership to Improve Patient Care was sent to the Center for Medicare and Medicaid Services (CMS). Along with the 147 patients’ groups, 241 doctors’ groups and pharmaceutical industry groups — both of which benefit from the maintaining the status quo of the current reimbursement method — signed either of the two letters opposing the reform. The letters’ combination of patients’ groups as well as industry groups, such as local Biotechnology Innovation Organization (BIO) affiliates, demonstrates the close ties patients’ groups have with the pharmaceutical industry.

In 2015, Part B spending reached $22 billion, double the amount it was in 2007. A reform such as this is necessary in order to remedy Medicare Part B’s unsustainable spending trend. The Medicare Part B demonstration, which is supported by numerous consumer interest groups including Public Citizen, aims to remove incentives for doctors to unnecessarily prescribe higher priced medicines when effective and affordable alternatives are available. Currently a physician who administers a drug under Medicare Part B will be reimbursed for the average sales price plus six percent. The demonstration proposes changing the reimbursement to the average sales price plus 2.5 percent and a flat dollar amount.

The pharmaceutical industry is strongly opposed to this reform because a decrease in the prescription of higher-priced drugs means a decrease in the industry’s profits. In fact, the industry has already spent more than $9 million in campaign funding for members of Congress, which is strongly correlated with lawmakers’ stances on the issue, as revealed by another recent Public Citizen report.

The pharmaceutical industry’s troubling pattern of influence raises questions about the independence of this reform’s opponents. Patients’ groups should reconsider their stance on this issue and realize that in this debate pharma is only looking out for itself, not for the deserving patients of this country.

© Copyright . All Rights Reserved.